Decheng Capital Management Iii (Cayman), LLC Beyond Spring Inc. Transaction History

Decheng Capital Management Iii (Cayman), LLC

  • $181 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 29, 2023
BUY
$0.75 - $1.16 $3.72 Million - $5.75 Million
4,958,143 New
4,958,143 $3.97 Million
Q1 2023

May 10, 2023
BUY
$1.06 - $3.05 $5.26 Million - $15.1 Million
4,958,143 New
4,958,143 $5.55 Million
Q3 2022

Nov 08, 2022
BUY
$0.97 - $1.81 $0 - $1
1 Added 0.0%
4,958,143 $4.91 Million
Q1 2022

May 10, 2022
BUY
$1.68 - $5.01 $8.33 Million - $24.8 Million
4,958,142 New
4,958,142 $10.9 Million

Others Institutions Holding BYSI

# of Institutions
21
Shares Held
5.55M
Call Options Held
26K
Put Options Held
2.4K
View Full List

About BeyondSpring Inc.

BYSI Quotes by TradingView
  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $66.6M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Decheng Capital Management Iii (Cayman), LLC Portfolio

Follow Decheng Capital Management Iii (Cayman), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email